From the World Congress of Oncology (ASCO), which closed yesterday, comes one last piece of good news …
asco2021
-
-
Use side effects as a signal that the tumor will respond to immunotherapy. We are talking about …
-
Health
Breast cancer, targeted therapy for the Brca mutation reduces the risk of recurrence
by adminFor women who have had triple negative breast cancer and have a mutation in the Brca genes, …
-
The history of immunotherapy, as with many innovative anti-cancer approaches, started from those cases where the treatments …
-
To date, there are no therapies for patients with kidney cancer at high risk of recurrence, and …
-
In recent years, immunotherapy has been the real novelty on the front of oncological therapies, demonstrating an …
-
With one million new cases diagnosed each year, gastric and gastroesophageal cancers represent the fourth leading cause …
-
An important result, because for the first time even in esophageal cancer, immunotherapy takes the effectiveness of …
-
The benefits in terms of overall and progression-free survival are also confirmed after five years for patients …
-
Genomic tests are a valuable tool to make breast cancer treatment truly tailor-made for each patient. The …